Table 4

Genital type-specific HPV distribution in men by circumcision status
HPV Circumcision N total PR (95% CI)
No Yes
N % N %
Oncogenic
16 190 7.5 117 8.2 307 1.10 (0.88-1.37)
18 51 2.0 40 2.8 91 1.40 (0.93-2.11)
31 51 2.0 20 1.4 71 0.70 (0.42-1.17)
33 20 0.8 4 0.3 24 0.36 (0.12-1.04)
35 41 1.6 24 1.7 65 1.05 (0.63-1.72)
39 96 3.8 49 3.4 145 0.91 (0.65-1.28)
45 47 1.8 18 1.3 65 0.68 (0.40-1.17)
51 158 6.2 95 6.7 253 1.07 (0.84-1.37)
52 166 6.5 78 5.5 244 0.84 (0.65-1.09)
56 55 2.2 20 1.4 75 0.65 (0.39-1.08)
58 71 2.8 27 1.9 98 0.68 (0.44-1.05)
59 131 5.1 91 6.4 222 1.24 (0.96-1.61)
68 54 2.1 37 2.6 91 1.22 (0.81-1.85)
Non-oncogenic
6 156 6.1 84 5.9 240 0.96 (0.74-1.24)
11 43 1.7 11 0.8 54 0.46 (0.24-0.88)
26 4 0.2 4 0.3 8 1.79 (0.45-7.14)
40 54 2.1 9 0.6 63 0.30 (0.15-0.60)
42 40 1.6 15 1.1 55 0.67 (0.37-1.21)
53 141 5.5 86 6.0 227 1.09 (0.84-1.41)
54 56 2.2 34 2.4 90 1.09 (0.71-1.65)
55 64 2.5 35 2.5 99 0.98 (0.65-1.47)
61 147 5.8 39 2.7 186 0.47 (0.34-0.67)
62 218 8.6 102 7.2 320 0.84 (0.67-1.05)
64 3 0.1 1 0.1 4 0.60 (0.06-5.72)
66 124 4.9 81 5.7 205 1.17 (0.89-1.53)
67 16 0.6 4 0.3 20 0.45 (0.15-1.33)
69 7 0.3 1 0.1 8 0.26 (0.03-2.07)
70 71 2.8 29 2.0 100 0.73 (0.48-1.12)
71 53 2.1 5 0.4 58 0.17 (0.07-0.42)
72 39 1.5 12 0.8 51 0.55 (0.29-1.05)
73 51 2.0 22 1.5 73 0.77 (0.47-1.27)
81 94 3.7 28 2.0 122 0.53 (0.35-0.81)
82 18 0.7 12 0.8 30 1.19 (0.58-2.47)
83 81 3.2 31 2.2 112 0.68 (0.45-1.03)
84 197 7.7 119 8.4 316 1.08 (0.87-1.34)
IS39 20 0.8 6 0.4 26 0.54 (0.22-1.33)
CP6108 162 6.4 113 7.9 275 1.25 (0.99-1.57)

NOTE.PR, prevalence ratio; CI, confidence interval. Numbers in bold correspond to statistically significant point estimates.

Albero et al.

Albero et al. BMC Infectious Diseases 2013 13:18   doi:10.1186/1471-2334-13-18

Open Data